Publications:

Caveolin-1 and Sox-2 are predictive biomarkers of cetuximab response in head and neck cancer.

Jci Insight

Bouhaddou, Mehdi M; Lee, Rex H RH; Li, Hua H; Bhola, Neil E NE; O'Keefe, Rachel A RA; Naser, Mohammad M; Zhu, Tian Ran TR; Nwachuku, Kelechi K; Duvvuri, Umamaheswar U; Olshen, Adam B AB; Roy, Ritu R; Hechmer, Aaron A; Bolen, Jennifer J; Keysar, Stephen B SB; Jimeno, Antonio A; Mills, Gordon B GB; Vandenberg, Scott S; Swaney, Danielle L DL; Johnson, Daniel E DE; Krogan, Nevan J NJ; Grandis, Jennifer R JR

Publication Date: 2021-10-22

Variant appearance in text: EGFR: E27A

PubMed Link: 34546978

Variant Present in the following documents:

• Main text

View BVdb publication page

Antibody Screening System Using a Herpes Simplex Virus (HSV)-Based Probe To Identify a Novel Target for Receptor-Retargeted Oncolytic HSVs.

Journal Of Virology

Ikeda, Hitomi H; Uchida, Hiroaki H; Okubo, Yu Y; Shibata, Tomoko T; Sasaki, Yasuhiko Y; Suzuki, Takuma T; Hamada-Uematsu, Mika M; Hamasaki, Ryota R; Okuda, Kosaku K; Yamaguchi, Miki M; Kojima, Masaki M; Tanaka, Masato M; Hamada, Hirofumi H; Tahara, Hideaki H

Publication Date: 2021-04-12

Variant appearance in text: EGFR: E27A

PubMed Link: 33627393

Variant Present in the following documents:

• Main text

View BVdb publication page